The Oxygen Therapy Market size in Europe was worth USD 0.59 billion in 2022 and is estimated to be growing at a CAGR of 5.77% to reach USD 0.78 billion by 2027.
Oxygen Therapy devices are useful, especially for people suffering from severe COPD or cystic fibrosis who suffer from chronically low oxygen levels in their bodies. The advantages of oxygen therapy include increased mental stamina, aversion to heart failure, and an enhanced breathing pattern. The administration and supply of supplementary oxygen have turned into an indispensable part of the management of numerous diseases. Furthermore, oxygen therapy applies to numerous diseases, for example, asthma, respiratory distress syndrome, and obstructive sleep apnea. Long-term oxygen treatments in patients suffering from chronic lung disease are believed to enhance life length and quality.
In Europe, the prevalence of COPD varies markedly across countries. For example, the Ministère de la Santé et des Solidaritiés estimates that between 6% and 8% of the adult population in France suffers from COPD. Interestingly, the Netherlands displays a 2% prevalence rate as evaluated by the National Institute for Public Health and the Environment. Generally, these devices are used to treat patients who are no longer able to receive adequate oxygen volumes through the breathing of natural air and require higher concentrations of oxygen.
A significant increase is expected in the number of patients on oxygen therapy as the population ages. As members of the 50 to 75 age demographics, who were often smokers in their youth, develop emphysema and related conditions. It is estimated that over 85% of the patients on oxygen therapy are once smokers.
This research report on the European Oxygen Therapy Market has been segmented & sub-segmented into the following categories:
By Product Type:
Regionally, Europe has the second-highest revenue in the oxygen therapy devices market and is expected to grow further in the coming years. Favorable government policies and initiatives such as the Europe Committee for Hyperbaric Medicine (ECHM) involved promoting awareness pertaining to the treatment and thereby promoting the growth of the oxygen therapy devices market.
Companies leading the EU Oxygen Therapy Market are Chart Industries Inc., Invacare Corporation, Becton, Dickinson and Company, Smiths Medical, Teleflex Incorporated, Inogen, Inc., DeVilbiss Healthcare, Essex Industries, Inc., Allied Healthcare Products Inc., and Respan Products Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com